Several blood-based biomarkers have shown associations with DKD progression, most significantly soluble tumor necrosis factor receptors 1/2 (TNFR1/2), and plasma KIM-1 [10, 11]. This evidence concerns the gene TNFRSF1A and diabetic kidney disease.